Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthesis and antimicrobial evaluation of new nitric oxide‐donating fluoroquinolone/oxime hybrids
Hossameldin A. Aziz, Gamal A. I. Moustafa, Gamal El‐Din A. Abuo‐Rahma, et al.
Archiv der Pharmazie (2020) Vol. 354, Iss. 1
Open Access | Times Cited: 15

Showing 15 citing articles:

The antibacterial activity of fluoroquinolone derivatives: An update (2018–2021)
Yanshu Jia, Liyan Zhao
European Journal of Medicinal Chemistry (2021) Vol. 224, pp. 113741-113741
Closed Access | Times Cited: 54
In silico drug design strategies for discovering novel tuberculosis therapeutics
Christian S. Carnero Canales, Aline Renata Pavan, Jean Leandro dos Santos, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 4, pp. 471-491
Closed Access | Times Cited: 7
From Infection to Tumor: Exploring the Therapeutic Potential of Ciprofloxacin Derivatives as Anticancer Agents
Hesham M. Hassan, Roket Hassan, Ranya Mohammed Elmagzoub, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 72-72
Open Access
Recent advancements and developments in search of anti-tuberculosis agents: A quinquennial update and future directions
Tejas M. Dhameliya, Kaushikkumar A. Bhakhar, Normi D. Gajjar, et al.
Journal of Molecular Structure (2021) Vol. 1248, pp. 131473-131473
Closed Access | Times Cited: 32
Current scenario of quinolone hybrids with potential antibacterial activity against ESKAPE pathogens
Jingyue Gao, Haodong Hou, Feng Gao
European Journal of Medicinal Chemistry (2022) Vol. 247, pp. 115026-115026
Closed Access | Times Cited: 25
Novel 4-(piperazin-1-yl)quinolin-2(1H)-one bearing thiazoles with antiproliferative activity through VEGFR-2-TK inhibition
Abdelfattah Hassan, Mohamed Badr, Heba A. Hassan, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 40, pp. 116168-116168
Closed Access | Times Cited: 30
Thiazolidine-2,4-dione-linked ciprofloxacin derivatives with broad-spectrum antibacterial, MRSA and topoisomerase inhibitory activities
Hossameldin A. Aziz, Ahmed M. M. El‐Saghier, Mohamed Badr, et al.
Molecular Diversity (2021) Vol. 26, Iss. 3, pp. 1743-1759
Closed Access | Times Cited: 27
A Comprehensive Review on Chemical Synthesis and Chemotherapeutic Potential of 3-Heteroaryl Fluoroquinolone Hybrids
Halyna Hryhoriv, Sergiy M. Kovalenko, Marine Georgiyants, et al.
Antibiotics (2023) Vol. 12, Iss. 3, pp. 625-625
Open Access | Times Cited: 11
Design, synthesis and mechanistic study of N-4-Piperazinyl Butyryl Thiazolidinedione derivatives of ciprofloxacin with Anticancer Activity via Topoisomerase I/II inhibition
Hossameldin A. Aziz, Ahmed M. M. El‐Saghier, Mohamed Badr, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Drug re‐engineering and repurposing: A significant and rapid approach to tuberculosis drug discovery
Dinesh S. Reddy, Anamika Sinha, Amit Kumar, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 11
Closed Access | Times Cited: 16
Synthesis and molecular docking of new N4-piperazinyl ciprofloxacin hybrids as antimicrobial DNA gyrase inhibitors
Hamada H. H. Mohammed, Doaa Mohamed Elroby Ali, Mohamed Badr, et al.
Molecular Diversity (2022) Vol. 27, Iss. 4, pp. 1751-1765
Open Access | Times Cited: 15
The Antibacterial Potential of Ciprofloxacin Hybrids against Staphylococcus aureus
Wenhua Zang, Danxia Li, Gao Li, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 12, pp. 1020-1034
Closed Access | Times Cited: 8
Biomedical applications of polymeric nitric oxide (NO) donors
Soumya Paul, Manish Kumar, Arindam Mukherjee, et al.
Elsevier eBooks (2023), pp. 21-53
Closed Access | Times Cited: 3
Design, synthesis, and biological evaluation of pyrazole-ciprofloxacin hybrids as antibacterial and antibiofilm agents against Staphylococcus aureus
Ojaswitha Ommi, Priyanka Sudhir Dhopat, Shashikanta Sau, et al.
RSC Medicinal Chemistry (2024)
Closed Access
Synthesis and antitumor activity evaluation of coumarin Mannich base derivatives
Bing He, Le Ding, Hong‐zhou Tan, et al.
Chemical Biology & Drug Design (2023) Vol. 103, Iss. 1
Closed Access | Times Cited: 1
Page 1

Scroll to top